These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25476516)

  • 1. Genomics of brain tumor imaging.
    Pope WB
    Neuroimaging Clin N Am; 2015 Feb; 25(1):105-19. PubMed ID: 25476516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging genomics of Glioblastoma: state of the art bridge between genomics and neuroradiology.
    ElBanan MG; Amer AM; Zinn PO; Colen RR
    Neuroimaging Clin N Am; 2015 Feb; 25(1):141-53. PubMed ID: 25476518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
    Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
    BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging and genetic influence in treating brain neoplasms.
    Hygino da Cruz LC; Kimura M
    Neuroimaging Clin N Am; 2015 Feb; 25(1):121-40. PubMed ID: 25476517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Genomics in Glioblastoma Multiforme: A Predictive Tool for Patients Prognosis, Survival, and Outcome.
    Anil R; Colen RR
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):731-740. PubMed ID: 27742113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics in Brain Tumors: An Emerging Technique for Characterization of Tumor Environment.
    Kotrotsou A; Zinn PO; Colen RR
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):719-729. PubMed ID: 27742112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
    Elshafeey N; Hassan I; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering gene-environment interactions in glioblastoma through a comprehensive data integration bioinformatics method.
    Kunkle B; Yoo C; Roy D
    Neurotoxicology; 2013 Mar; 35():1-14. PubMed ID: 23261424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics, Metabolic, and Molecular MRI for Brain Tumors.
    Kickingereder P; Andronesi OC
    Semin Neurol; 2018 Feb; 38(1):32-40. PubMed ID: 29548050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Genomics of Glioblastoma: Biology, Biomarkers, and Breakthroughs.
    Moton S; Elbanan M; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2015 Jun; 24(3):155-63. PubMed ID: 26049819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning can see the unseeable: predicting molecular markers from MRI of brain gliomas.
    Korfiatis P; Erickson B
    Clin Radiol; 2019 May; 74(5):367-373. PubMed ID: 30850092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance metabolic imaging of glioma.
    Metellus P; Figarella-Branger D
    Sci Transl Med; 2012 Jan; 4(116):116ps1. PubMed ID: 22238331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic signature of adult gliomas and correlation with MRI features.
    Bruzzone MG; Eoli M; Cuccarini V; Grisoli M; Valletta L; Finocchiaro G
    Expert Rev Mol Diagn; 2009 Oct; 9(7):709-20. PubMed ID: 19817555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics.
    Ellingson BM
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):506. PubMed ID: 25410316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Baxter LC; Gaw N; Ranjbar S; Plasencia J; Dueck AC; Peng S; Smith KA; Nakaji P; Karis JP; Quarles CC; Wu T; Loftus JC; Jenkins RB; Sicotte H; Kollmeyer TM; O'Neill BP; Elmquist W; Hoxworth JM; Frakes D; Sarkaria J; Swanson KR; Tran NL; Li J; Mitchell JR
    Neuro Oncol; 2017 Jan; 19(1):128-137. PubMed ID: 27502248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.
    Magnus N; Meehan B; Garnier D; Hashemi M; Montermini L; Lee TH; Milsom C; Pawlinski R; Ohlfest J; Anderson M; Mackman N; Rak J
    Biochem Biophys Res Commun; 2014 Nov; 454(2):262-8. PubMed ID: 25450387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma: molecular analysis and clinical implications.
    Huse JT; Holland E; DeAngelis LM
    Annu Rev Med; 2013; 64():59-70. PubMed ID: 23043492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
    NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.